NLRP2 Chromosome 19
NLR family pyrin domain containing 2
Upload your DNA to see your personal genotypes for variants in NLRP2.
What This Gene Does
This gene is a member of the nucleotide-binding and leucine-rich repeat receptor (NLR) family, and is predicted to contain an N-terminal pyrin effector domain (PYD), a centrally-located nucleotide-binding and oligomerization domain (NACHT) and C-terminal leucine-rich repeats (LRR). Members of this gene family are thought to be important regulators of immune responses. This gene product interacts with components of the IkB kinase (IKK) complex, and can regulate both caspase-1 and NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity. The pyrin domain is necessary and sufficient for suppression of NF-kB activity. An allelic variant (rs147585490) has been found that is incapable of blocking the transcriptional activity of NF-kB. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
Gene Info
Gene Group
"NLR family|Pyrin domain containing"
Locus Type
gene with protein product
Location
19q13.42
Ensembl
ENSG00000022556
Associated Conditions (2)
Oocyte/zygote/embryo maturation arrest 18
Multisystem inflammatory syndrome in children
Key Variants
RS149735961
Conflicting classifications of pathogenicity
Health Risk
RS150431153
Conflicting classifications of pathogenicity
Health Risk
RS753221956
Conflicting classifications of pathogenicity
Health Risk
RS777564374
Conflicting classifications of pathogenicity
Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18
Health Risk
RS1194295774
Pathogenic
Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18
Health Risk
RS1266848624
Pathogenic
Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18
Health Risk
RS779493327
Pathogenic
Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18
Health Risk
RS2146427557
risk factor
Multisystem inflammatory syndrome in children, Multisystem inflammatory syndrome in children
Health Risk
All Variants (8)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS149735961 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS150431153 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS753221956 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS777564374 | Health Risk | Conflicting classifications of pathogenicity | Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18 |
| RS1194295774 | Health Risk | Pathogenic | Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18 |
| RS1266848624 | Health Risk | Pathogenic | Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18 |
| RS779493327 | Health Risk | Pathogenic | Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18 |
| RS2146427557 | Health Risk | risk factor | Multisystem inflammatory syndrome in children, Multisystem inflammatory syndrome in children |